Latham & Watkins Advises Surgical Specialties Corporation in its Sale by Vivo Capital and an Investor Syndicate to Corza Health

Vivo Capital, a global healthcare investment firm, has announced that it has closed the sale of Surgical Specialties Corporation to Corza Health, a portfolio company of GTCR, a global private equity firm.

February 01, 2021

Vivo Capital, a global healthcare investment firm, has announced that it has closed the sale of Surgical Specialties Corporation to Corza Health, a portfolio company of GTCR, a global private equity firm.

Latham & Watkins LLP advised Surgical Specialties Corporation in the transaction with a corporate deal team led by Boston partners Hans Brigham and Julie Scallen, with Boston associates Laki Triantafylidis and Michael Casagrande. Advice was also provided on regulatory matters by Washington, D.C. partner Elizabeth Richards and Bay Area counsel Betty Pang, with Washington, D.C. associate Barrett Tenbarge; on tax matters by Washington, D.C. partners Nicholas DeNovio, with Washington, D.C. associate Eli McCrain; on benefits and compensation matters by Chicago partner Robin Struve, with Chicago associates Leah Segall and Victoria Wolfe; on technology transactions matters by New York partner Alan Tamarelli, with Boston associate Seth Appiah-Opoku; on antitrust matters by Washington, D.C. partner Mandy Reeves and Washington, D.C. counsel Patrick English; on finance matters by New York partner Joshua Tinkelman; and on insurance matters by Los Angeles partner Drew Levin, with Los Angeles associate Harrison White.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.